A link between zinc transport and diabetes

Individuals with a mutation in the gene encoding a zinc transporter, SLC30A8 have an elevated risk of developing type 2 diabetes. Insulin granules that are released from pancreatic β cells contain high levels of zinc; however, it is not clear why individuals with mutations in the SLC30A8 zinc transporter gene are predisposed to type 2 diabetes.

In this issue of the Journal of Clinical Investigation, Yoshio Fujitani and colleagues at Juntendo University investigated the role of zinc transport by SLC30A8 in ? cells. They found that this zinc transporter is required for insulin clearance by the liver and secreted zinc signals to ? cells to stop releasing insulin.

In the accompanying commentary, Alan Attie and colleagues at the University of Wisconsin-Madison discuss the dynamic regulatory role of zinc in insulin regulation.


Explore further

Potential diagnostic marker for zinc status offers insights into the effects of zinc deficiency

More information: The diabetes-susceptible gene SLC30A8/ZnT8 regulates hepatic insulin clearance, J Clin Invest. 2013;123(10):4513–4524. DOI: 10.1172/JCI68807
Zinc, insulin, and the liver: a ménage à trois, J Clin Invest. 2013;123(10):4136–4139. DOI: 10.1172/JCI72325
Citation: A link between zinc transport and diabetes (2013, September 24) retrieved 20 October 2020 from https://medicalxpress.com/news/2013-09-link-zinc-diabetes.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments